March 2021

Optimus was established in the year 2004 as custom synthesis laboratory by a team of Technocrats. It is one of the fastest growing Manufacturer in Active Pharmaceutical Ingredients (APIs) and Finished dosages. Optimus Research Center for API & Formulations was set-up as a centralized Research and Development center to focus on Generic product developments suitable for regulated markets.

National Institute of Pharmaceutical Education & Research, Guwahati (NIPER-G) is an autonomous institute of National importance and the first national pharma institute in NE India set up by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Govt. of India by an act of parliament, to impart high quality Education & Research in the area of Pharmaceutical Sciences.

The Birla Institute of Technology & Science, BITS Pilani is an all-India Institute for higher education. The primary motive of BITS is to "train young men and women able and eager to create and put into action such ideas, methods, techniques and information". The Institute is a dream come true of its founder late Mr G.D.Birla - an eminent industrialist, a participant in Indian freedom struggle and a close associate of the Father of Indian Nation late Mr. Mohandas Karamchand Gandhi (Mahatma Gandhi).

The Indian Army promises both professional and personal growth at every stage of the career. Opportunities to excel through various courses are abundant including opportunities to enhance your educational qualification by availing two years paid study leave. The inherent adventure and extra-curricular activities in the Army ensure an all round development essential in today's world. Art of War-Engineering-Medicine-Administration-Human Resource Development and Management; the army teaches you all.

The University of Hyderabad, a premier institution of post graduate teaching and research in the country, was established by an Act of Parliament on 2nd October, 1974 as a Central University, wholly financed by the University Grants Commission.

GlaxoSmithKline Pharmaceuticals Ltd. (GSK Rx India) is one of the oldest pharmaceuticals company and employs over 5000+ people. Globally, we are a £ 27.4 billion, leading, research-based healthcare and pharmaceutical company. In India, we are one of the market leaders.

Post : Regulatory Specialist, CMC Renewals - Senior

At Indegene, we look to change healthcare for the better. Being an Indegene employee is not just doing a job, but it is about real contribution and outcomes. We are a global team of over 1,200 employees across 14 global locations. Our singular focus is to deliver real outcomes that are measurable, impactful, and sustainable. This has made us a recognized global leader and partner to some of the largest and most respected healthcare organizations.

Post : Associate Quality Assurance

The US District Court for the Northern District of West Virginia has decided in favour of AstraZeneca in litigation against Mylan Pharmaceuticals Inc. (Mylan) and Kindeva Drug Delivery L.P. (Kindeva), determining that asserted claims in three of AstraZeneca’s patents protecting Symbicort (budesonide/formoterol) in the US are not invalid.

Vir Biotechnology, Inc and GlaxoSmithKline plc provided an update on the VIR-7831 (GSK4182136) arm of the National Institutes of Health’s (NIH) Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Program Phase 3 clinical trial. The companies were informed that while VIR-7831 met initial pre-specified criteria to continue to the next phase of the ACTIV-3 trial and there were no reported safety signals, sensitivity analyses of the available data raised concerns about the magnitude of potential benefit.